|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/7064 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2574341 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12197499.2 |
| Date of filing the European patent application | 2005-03-29 | |
| (97) | Date of publication of the European application | 2013-04-03 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
| (46) | Date of publication of the claims translation | 2017-09-11 |
| (30) | Number | Date | Country code |
| 557599 P | 2004-03-29 | US |
| (72) |
Cheng, Jin Q., US
Sebti, Said M., US
|
| (73) |
UNIVERSITY OF SOUTH FLORIDA,
3702 Spectrum Blvd, Suite 155, Tampa, FL 33612,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Navikų ir vėžio efektyvus gydymas triciribino fosfatu |
| Effective treatment of tumors and cancer with triciribine phosphate |
| Payment date | Validity (years) | Amount | |
| 2023-03-09 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-03-29 |